Cyclo Therapeutics logo

Cyclo Therapeutics Share Price Today

(NASDAQ: CYTH)

Cyclo Therapeutics share price is $0.71 & ₹61.75 as on 6 Mar 2025, 2.30 'hrs' IST

$0.71

Market is closed - opens 8 PM, 06 Mar 2025

View live Cyclo Therapeutics share price in Dollar and Rupees. Guide to invest in Cyclo Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Cyclo Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Cyclo Therapeutics share price movements

  • Today's Low: $0.70
    Today's High: $0.76

    Day's Volatility :7.88%

  • 52 Weeks Low: $0.55
    52 Weeks High: $1.79

    52 Weeks Volatility :69.27%

Cyclo Therapeutics (CYTH) Returns

PeriodCyclo Therapeutics IncIndex (Russel 2000)
3 Months
18.27%
0.0%
6 Months
4.52%
0.0%
1 Year
-58.07%
0.0%
3 Years
-80.2%
-11.6%

Cyclo Therapeutics (CYTH) Key Statistics

in dollars & INR

Previous Close
$0.7125
Open
$0.71
Today's High
$0.76
Today's Low
$0.7001
Market Capitalization
$23.3M
Today's Volume
$32.1K
52 Week High
$1.79
52 Week Low
$0.55
Revenue TTM
$870.7K
EBITDA
$-24.7M
Earnings Per Share (EPS)
$-0.83
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-22663.91%

How to invest in Cyclo Therapeutics Stock (CYTH) from India?

It is very easy for Indian residents to invest directly in Cyclo Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Cyclo Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Cyclo Therapeutics or CYTH on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Cyclo Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Cyclo Therapeutics shares which would translate to 1.225 fractional shares of Cyclo Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Cyclo Therapeutics, in just a few clicks!

Returns in Cyclo Therapeutics (CYTH) for Indian investors in Rupees

The Cyclo Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Cyclo Therapeutics investment value today

Current value as on today

₹46,714

Returns

₹53,286

(-53.29%)

Returns from Cyclo Therapeutics Stock

₹58,235 (-58.24%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Cyclo Therapeutics (CYTH)

8400.0%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Investment in Cyclo Therapeutics Shares from India has grown by 8400.0% over the past 30 days, indicating increased transactional activity.

256%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Cyclo Therapeutics Stock from India on INDmoney has increased by 256% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Cyclo Therapeutics

    Analyst Recommendation on Cyclo Therapeutics

    Buy

      87%Buy

      12%Hold

      0%Sell

    Based on 8 Wall street analysts offering stock ratings for Cyclo Therapeutics(by analysts ranked 0 to 5 stars)

    Based on 8 analyst
    • Current
    • 1M Ago
    • 3M Ago
    Buy
    7
    6
    6
    Hold
    1
    1
    1
    Sell
    0
    0
    0

    Analyst Forecast on Cyclo Therapeutics Stock (CYTH)

    What analysts predicted

    Upside of 33.8%

    Target:

    $0.95

    Current:

    $0.71

    Insights on Cyclo Therapeutics Stock (Ticker Symbol: CYTH)

    • Price Movement

      In the last 3 months, CYTH stock has moved up by 16.9%
    • Increasing Revenue

      Revenue is up for the last 2 quarters, 123.10K → 233.77K (in $), with an average increase of 47.3% per quarter
    • Decreasing Net Profit

      Netprofit is down for the last 3 quarters, -4.34M → -8.83M (in $), with an average decrease of 42.7% per quarter
    • CYTH vs ITCI (1 yr)

      In the last 1 year, Intra-cellular Therapies, Inc. has given 98.7% return, outperforming this stock by 156.8%
    • CYTH vs ITCI (3 yr)

      In the last 3 years, Intra-cellular Therapies, Inc. has given 138.1% return, outperforming this stock by 217.5%
    • Price to Sales

      ForCYTH every $1 of sales, investors are willing to pay $22.3, whereas for Intra-cellular Therapies, Inc., the investors are paying $19.9 for every $1 of sales.

    Cyclo Therapeutics Technicals Summary

    Sell

    Neutral

    Buy

    Cyclo Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

    Cyclo Therapeutics (CYTH) Vs Peers

    Company Name1 Month6 Month1 Year3 Years5 Years
    Cyclo Therapeutics Inc logo
    -10.55%
    4.52%
    -58.07%
    -80.2%
    -83.03%
    Intra-cellular Therapies, Inc. logo
    3.38%
    81.15%
    98.68%
    146.46%
    588.66%
    Haleon Plc Spon Ads logo
    10.71%
    2.13%
    26.53%
    42.24%
    42.24%
    Zoetis Inc. logo
    -3.04%
    -10.5%
    -9.01%
    -11.21%
    28.74%
    Neurocrine Biosciences Inc. logo
    -25.31%
    -6.07%
    -13.91%
    29.45%
    28.72%
    Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
    Cyclo Therapeutics Inc logo
    NA
    NA
    NA
    0.0
    -226.64
    -2.84
    NA
    -0.47
    Intra-cellular Therapies, Inc. logo
    NA
    NA
    0.0
    0.13
    -0.09
    -0.07
    NA
    10.81
    Haleon Plc Spon Ads logo
    26.35
    26.35
    1.92
    0.36
    0.09
    0.04
    0.02
    1.8
    Zoetis Inc. logo
    31.17
    31.17
    3.01
    6.07
    0.51
    0.15
    0.01
    10.64
    Neurocrine Biosciences Inc. logo
    34.6
    34.6
    0.27
    6.44
    0.14
    0.1
    NA
    26.05
    Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
    Cyclo Therapeutics Inc logo
    Buy
    $23.3M
    -83.03%
    NA
    0.0%
    Intra-cellular Therapies, Inc. logo
    Buy
    $14.0B
    588.66%
    NA
    -10.97%
    Haleon Plc Spon Ads logo
    Buy
    $47.7B
    42.24%
    26.35
    12.84%
    Zoetis Inc. logo
    Buy
    $76.1B
    28.74%
    31.17
    26.86%
    Neurocrine Biosciences Inc. logo
    Buy
    $11.4B
    28.72%
    34.6
    14.49%

    About Cyclo Therapeutics

    Cyclo Therapeutics, Inc., a clinical stage biotechnology company, engages in the development of cyclodextrin-based products for the treatment of neurodegenerative diseases. The company's lead drug candidate is Trappsol Cyclo (hydroxypropyl beta cyclodextrin), an orphan drug, which is in Phase III clinical trials for the treatment of Niemann-Pick Type C disease; and in Phase IIb clinical trials for the treatment of Alzheimer's disease. It also sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs. The company was formerly known as CTD Holdings, Inc. and changed its name to Cyclo Therapeutics, Inc. in September 2019. Cyclo Therapeutics, Inc. was incorporated in 1990 and is headquartered in Gainesville, Florida. Cyclo Therapeutics, Inc. is a subsidiary of Rafael Holdings, Inc.
    Organization
    Cyclo Therapeutics
    Employees
    8
    CEO
    Mr. N. Scott Fine
    Industry
    Miscellaneous

    Management People of Cyclo Therapeutics

    NameTitle
    Mr. N. Scott Fine
    CEO & Director
    Mr. C. E Strattan
    Founder & Director
    Mr. Joshua M. Fine
    CFO & Secretary
    Mr. Michael Eric Lisjak
    Senior VP of Business Development & Chief Regulatory Officer
    Dr. Jeffrey L. Tate Ph.D.
    COO, Chief Quality Officer & Director
    Ms. Lori McKenna
    Global Head of Patient Advocacy
    Dr. Karen Mullen FFPM
    Interim Chief Medical Officer

    Important FAQs about investing in CYTH Stock from India :

    What is Cyclo Therapeutics share price today?

    Cyclo Therapeutics share price today stands at $0.71, Open: $0.71 ; Previous Close: $0.71 ; High: $0.76 ; Low: $0.70 ; 52 Week High: $1.79 ; 52 Week Low: $0.55.

    The stock opens at $0.71, after a previous close of $0.71. The stock reached a daily high of $0.76 and a low of $0.70, with a 52-week high of $1.79 and a 52-week low of $0.55.

    Can Indians buy Cyclo Therapeutics shares?

    Yes, Indians can invest in the Cyclo Therapeutics (CYTH) from India.

    With INDmoney, you can buy Cyclo Therapeutics at 0 brokerage. The step-by-step process is as follows:

    • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
    • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
    • Once funds are transferred successfully, you can buy Cyclo Therapeutics at zero transaction cost.

    How can I buy Cyclo Therapeutics shares from India?

    It is very easy to buy Cyclo Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

    Can Fractional shares of Cyclo Therapeutics (CYTH) be purchased?

    Yes, you can buy fractional shares of Cyclo Therapeutics with INDmoney app.

    What are the documents required to start investing in Cyclo Therapeutics stocks?

    To start investing in Cyclo Therapeutics, You will need the following documents:

    • Proof of Identification (PAN, Aadhaar etc)
    • Proof of address (Aadhaar, Voter ID etc)

    These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

    What are today’s High and Low prices of Cyclo Therapeutics Stock (CYTH)?

    Today’s highest price of Cyclo Therapeutics (CYTH) is $0.76.

    Today’s lowest price of Cyclo Therapeutics (CYTH) is $0.70.

    What is today's market capitalisation of Cyclo Therapeutics?

    Today's market capitalisation of Cyclo Therapeutics CYTH is 23.3M

    What is the 52 Week High and Low Range of Cyclo Therapeutics Stock (CYTH)?

    • 52 Week High

      $1.79

    • 52 Week Low

      $0.55

    What are the historical returns of Cyclo Therapeutics (CYTH)?

    • 1 Month Returns

      -10.55%

    • 3 Months Returns

      4.52%

    • 1 Year Returns

      -58.07%

    • 5 Years Returns

      -83.03%

    Who is the Chief Executive Officer (CEO) of Cyclo Therapeutics ?

    Mr. N. Scott Fine is the current Chief Executive Officer (CEO) of Cyclo Therapeutics.